Skip to main content

Advertisement

Fig. 5 | BMC Cancer

Fig. 5

From: FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFκB pathway

Fig. 5

FAM168A interference affects K562 cell cycle. The K562 cells were transfected with FAM168A siRNA or negative control siRNA, respectively, and cultured for 48 h. Cells were harvested for flow cytometry and Western blot analysis. a Flow cytometric results of K562 cells transfected with the negative control siRNA for 48 h. b Flow cytometric results of K562 cells transfected with FAM168A siRNA for 48 h. c Western blot images of FAM168A and Cyclin B1 in K562 cells transfected with FAM168A siRNA or negative control siRNA. d Quantitative results of protein levels of FAM168A and Cyclin B1 in K562 cells transfected with FAM168A siRNA or negative control siRNA. Data were presented as mean ± SD from three independent experiments. **p < 0.01

Back to article page